Zhong Yuan Bio-Technology Holdings Limited
ZHYBF · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,278 | $1,663 | $2,329 | $1,635 |
| % Growth | 37% | -28.6% | 42.4% | – |
| Cost of Goods Sold | $206 | $145 | $420 | $282 |
| Gross Profit | $2,072 | $1,518 | $1,908 | $1,353 |
| % Margin | 90.9% | 91.3% | 82% | 82.8% |
| R&D Expenses | $494 | $358 | $680 | $211 |
| G&A Expenses | $898 | $754 | $1,026 | $575 |
| SG&A Expenses | $1,311 | $2,414 | $1,914 | $1,157 |
| Sales & Mktg Exp. | $414 | $1,680 | $888 | $582 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,805 | $2,771 | $2,594 | $1,368 |
| Operating Income | $267 | -$1,253 | -$686 | -$15 |
| % Margin | 11.7% | -75.4% | -29.5% | -0.9% |
| Other Income/Exp. Net | $5 | -$506 | $14 | -$13 |
| Pre-Tax Income | $271 | -$1,759 | -$672 | -$28 |
| Tax Expense | -$1 | -$9 | $11 | $0 |
| Net Income | $302 | -$2,231 | -$1,126 | -$28 |
| % Margin | 13.3% | -134.2% | -48.3% | -1.7% |
| EPS | 0.017 | -0.12 | -0.065 | -0.002 |
| % Growth | 114.2% | -84.3% | -3,968.8% | – |
| EPS Diluted | 0.017 | -0.12 | -0.065 | -0.002 |
| Weighted Avg Shares Out | 17,748 | 17,666 | 17,283 | 17,145 |
| Weighted Avg Shares Out Dil | 17,992 | 17,666 | 17,283 | 17,145 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24 | $1 | $0 | $0 |
| Interest Expense | $81 | $47 | $35 | $25 |
| Depreciation & Amortization | $123 | $159 | $183 | $182 |
| EBITDA | $475 | -$1,472 | -$453 | $179 |
| % Margin | 20.9% | -88.5% | -19.5% | 10.9% |